- Home
- NAUT vs RXST Comparison
NAUT vs RXST Comparison
Compare NAUT & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NAUT | RXST |
|---|---|---|
| Founded | 2016 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 218.6M | 232.2M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NAUT | RXST |
|---|---|---|
| Price | $1.69 | $5.19 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 10 |
| Target Price | $4.00 | ★ $9.78 |
| AVG Volume (30 Days) | 1.2M | ★ 1.4M |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 16.07 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $134,479,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $992.86 | $10.06 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.62 | $4.48 |
| 52 Week High | $4.31 | $13.22 |
Technical Indicators
Market Signals| Indicator | NAUT | RXST |
|---|---|---|
| Relative Strength Index (RSI) | 38.80 | 48.76 |
| Support Level | $1.61 | $4.60 |
| Resistance Level | $1.87 | $5.92 |
| Average True Range (ATR) | 0.11 | 0.43 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 29.29 | 39.11 |
Price Performance
Historical ComparisonAbout NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.